Gum disease and hepatitis: a hidden connection revealed?

NCT ID NCT07491848

Recruiting now Knowledge-focused Sponsor: Research Center of Periodontal-Systemic Interactions Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the link between gum (periodontal) disease and hepatitis B+D infection, and whether the drug bulevirtide changes that relationship. Researchers will measure inflammation markers in saliva and gum fluid from 25 adults: those with hepatitis B+D on bulevirtide, those not on the drug, and healthy volunteers. The goal is to better understand how these conditions interact, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis B virus infection hepatitis D virus infection periodontitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATITIS B， CHRONIC HEPATITIS D PERIODONTITIS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Emergency County Hospital Craiova
RECRUITING

Craiova, Romania

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Medicine and Pharmacy of Craiova
RECRUITING

Craiova, Romania

Contact Phone: •••-•••-•••• Email: •••••@•••••